Molecular detection of oncogenic subtypes of human papillomavirus (HPV) in a group of women in the Amazon region of Brazil

被引:2
作者
Silva e Silva, Alessandra [1 ]
Bica, Claudia Giuliano [2 ]
Vieira, Anifisca [2 ]
Fantin, Cleiton [1 ]
机构
[1] Univ Estado Amazonas, Lab Genom & Prote, Av Djalma Batista 3578, BR-69055010 Manaus, Amazonas, Brazil
[2] Univ Fed Ciencias Saude, Lab Pesquisa Patol, Porto Alegre, RS, Brazil
关键词
cervical cancer; human papillomavirus; Amazon; INFECTION; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; PATHOLOGY; PCR;
D O I
10.4025/actascihealthsci.v42i1.50005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The natural history of cervical cancer is strongly related to the presence of human papillomavirus (HPV) infection, with its relationship with cervical cancer being a matter of concern. It is estimated that 70% of all cervical cancers worldwide are caused by HPV 16 and 18. Accordingly, the present study aimed to contribute to the identification of HPV subtypes circulating in a group of women of Manaus-Brazil. Cervical samples were collected from 49 women, following the eligibility criteria of the study, and DNA was then extracted from the samples, which were analyzed for the presence of the virus in the genetic material through the polymerase chain reaction (PCR) using generic primers (GP05/06). Finally, identification of the viral subtypes was performed using specific primers for the detection of the main subtypes already examined (16 and 18). Positive HPV DNA was detected in 100% of the samples included in the study. Human papillomavirus 16 was the most prevalent subtype in the majority of lesions, accounting for 29 (59.2%) of the positive cases, and HPV 18 was detected in four (8.2%) women. In these 4 cases there was co-infection, with the presence of both HPV 18 and HPV 16. Therefore, 40.8% (20 cases) in which HPV DNA was detected presented infection with other subtypes of HPV not included in the study. This data has clinical implications related to cervical cancer prevention, as the current prophylactic HPV vaccines are only effective against high-risk HPV 16 and 18 subtypes.
引用
收藏
页数:8
相关论文
共 30 条
  • [1] Albring L., 2006, Revista Brasileira de Analises Clinicas, V38, P87
  • [2] The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies -: A study with human papillomavirus deoxyribonucleic acid sequence analysis
    Andersson, S
    Mints, M
    Sällström, J
    Wilander, E
    [J]. CANCER DETECTION AND PREVENTION, 2004, 29 (01): : 37 - 41
  • [3] [Anonymous], 2015, CONS NAC NUTR ONC
  • [4] The epidemiology of human papillomavirus infection and cervical cancer
    Bosch, F. Xavier
    de Sanjose, Silvia
    [J]. DISEASE MARKERS, 2007, 23 (04) : 213 - 227
  • [5] Comparison of HPV genotyping by type-specific PCR and sequencing
    Carvalho, Nara de Oliveira
    del Castillo, Dora Mendez
    Perone, Carlos
    Januario, Jose Nelio
    de Melo, Victor Hugo
    Brasileiro Filho, Geraldo
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2010, 105 (01): : 73 - 78
  • [6] The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan
    Chang, CH
    Chen, TH
    Hsu, RC
    Chou, PH
    Yang, JH
    Hwang, GY
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2005, 32 (01) : 33 - 37
  • [7] da Rosa MI, 2009, CAD SAUDE PUBLICA, V25, P952
  • [8] de Almeida LM, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/1645074
  • [9] Oliveira Ledy do Horto dos Santos, 2003, Sao Paulo Med. J., V121, P67, DOI 10.1590/S1516-31802003000200007
  • [10] Doyle JJ., 1987, Phytochemical Bulletin, V19, P11, DOI [DOI 10.2307/4119796, DOI 10.1016/0031-9422(80)85004-7]